Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Herz
Erschienen in: Herz 6/2019

01.07.2019 | Angeborene Herzfehler | CME

Medizinische Versorgung von Erwachsenen mit angeborenen Herzfehlern

Gegenwart und Zukunft

verfasst von: Dr. phil. R. Neidenbach, M.Sc., S. Achenbach, C. Andonian, J. Beckmann, S. Biber, S. Dittrich, P. Ewert, S. Freilinger, M. Huntgeburth, N. Nagdyman, R. Oberhoffer, L. Pieper, Y. von Kodolitsch, M. Weyand, U. M. M. Bauer, Prof. Dr. Dr. H. Kaemmerer

Erschienen in: Herz | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Angeborene Herzfehler (AHF) sind die häufigsten angeborenen Organanomalien. Dank medizinischer Fortschritte erreichen heutzutage fast alle Patienten das Erwachsenenalter. Trotz primär erfolgreicher Behandlungen können Rest- und Folgezustände sowie (nicht-)kardiale Komorbiditäten den chronischen Krankheitsverlauf beeinflussen und zu einer erhöhten Morbidität und Mortalität führen. Erwachsene mit angeborenen Herzfehlern (EmaH) in Deutschland sind trotz des großen Nachsorgebedarfs nicht an die Versorgungsstrukturen angebunden. Daten der VEmaH-Studie („Versorgungssituation von EmaH“) belegen, dass EmaH und primär betreuende Haus- und Allgemeinärzte hinsichtlich des Komplikationspotenzials von AHF und der Notwendigkeit einer fachspezifischen Nachsorge enorme Informationsdefizite aufweisen. Eine optimierte, zukunftsorientierte Versorgung erfordert eine regelmäßige Nachsorge und die Möglichkeit zur fächerübergreifenden, integrierten medizinischen Versorgung von AHF im Langzeitverlauf.
Literatur
1.
Neidenbach R, Kaemmerer H, Pieper L et al (2017) Striking supply gap in adults with congenital heart disease? Dtsch Med Wochenschr 142(4):301–303CrossRefPubMed
2.
Neidenbach R, Pieper L, Sanftenberg L et al (2018) Adults with congenital heart disease: Lack of specific disease related medical health care from the general practitioners view. Eur Heart J 39:112
3.
Neidenbach R, Pieper L, Freilinger S et al (2018) Adults with congenital heart disease: Lack of specific disease related medical health care from the patients point of view. Eur Heart J 39:111
4.
Singh S, Desai R, Fong HK et al (2018) Extra-cardiac comorbidities or complications in adults with congenital heart disease: A nationwide inpatient experience in the United States. Cardiovasc Diagn Ther 8(6):814–819CrossRefPubMedPubMedCentral
5.
Neidenbach RC, Lummert E, Vigl M et al (2018) Non-cardiac comorbidities in adults with inherited and congenital heart disease: Report from a single center experience of more than 800 consecutive patients. Cardiovasc Diagn Ther 8(4):423–431CrossRefPubMedPubMedCentral
6.
Andonian C, Beckmann J, Biber S et al (2018) Current research status on the psychological situation of adults with congenital heart disease. Cardiovasc Diagn Ther 8(6):799–804CrossRefPubMedPubMedCentral
7.
Deutsche Herzstiftung e. V. (2019) Deutscher Herzbericht 2018
8.
Kaemmerer H, Breithardt G (2006) Recommendations for the quality improvement of interdisciplinary care of adults with congenital heart anomalies. Clin Res Cardiol 95(Suppl 4):76–84CrossRefPubMed
9.
Perloff JK, Warnes CA (2001) Challenges posed by adults with repaired congenital heart disease. Circulation 103(21):2637–2643CrossRefPubMed
10.
Neidenbach R, Niwa K, Oto O et al (2018) Improving medical care and prevention in adults with congenital heart disease—reflections on a global problem—Part I: Development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia. Cardiovasc Diagn Ther 8(6):705–715CrossRefPubMedPubMedCentral
11.
Neidenbach R, Niwa K, Oto O et al (2018) Improving medical care and prevention in adults with congenital heart disease—reflections on a global problem—Part II: Infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy. Cardiovasc Diagn Ther 8(6):716–724CrossRefPubMedPubMedCentral
12.
13.
Neidenbach R, Nagdyman N, Oberhoffer R, Kaemmerer H (2017) Angeborene Herzfehler im Langzeitverlauf. Pädoatrie 29(6):28–33
14.
Engelings CC, Helm PC, Abdul-Khaliq H et al (2016) Cause of death in adults with congenital heart disease—An analysis of the German national register for congenital heart defects. Int J Cardiol 211:31–36CrossRefPubMed
15.
Ministeri M, Alonso-Gonzalez R, Swan L, Dimopoulos K (2016) Common long-term complications of adult congenital heart disease: Avoid falling in a H.E.A.P. Expert Rev Cardiovasc Ther 14(4):445–462CrossRefPubMed
16.
Zomer AC, Vaartjes I, van der Velde ET et al (2013) Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol 168(3):2487–2493CrossRefPubMed
17.
Faccini A, Micheletti A, Negura D et al (2018) Heart failure in grown-up congenital heart disease. Minerva Cardioangiol 66(3):329–336PubMed
18.
Van De Bruaene A, Meier L, Droogne W et al (2018) Management of acute heart failure in adult patients with congenital heart disease. Heart Fail Rev 23(1):1–14CrossRef
19.
Budts W, Roos-Hesselink J, Radle-Hurst T et al (2016) Treatment of heart failure in adult congenital heart disease: A position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 37(18):1419–1427CrossRefPubMedPubMedCentral
20.
Brida M, Diller G‑P, Gatzoulis MA (2018) Systemic right ventricle in adults with congenital heart disease: Anatomic and phenotypic spectrum and current approach to management. Circulation 137(5):508–518CrossRefPubMed
21.
Derk G, Houser L, Miner P et al (2015) Efficacy of endothelin blockade in adults with Fontan physiology. Congenit Heart Dis 10(1):E11–E16CrossRefPubMed
22.
Koyak Z, de Groot JR, Krimly A et al (2018) Cardiac resynchronization therapy in adults with congenital heart disease. Europace 20(2):315–322CrossRefPubMed
23.
Khairy P, Van Hare GF, Balaji S et al (2014) PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol 30(10):e1–e63CrossRefPubMed
24.
Cedars A, Vanderpluym C, Koehl D et al (2018) An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant 37(5):619–630CrossRefPubMed
25.
VanderPluym CJ, Cedars A, Eghtesady P et al (2018) Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant 37(1):89–99CrossRefPubMed
26.
27.
Oechslin EN, Harrison DA, Connelly MS et al (2000) Mode of death in adults with congenital heart disease. Am J Cardiol 86(10):1111–1116CrossRefPubMed
28.
Nieminen HP, Jokinen EV, Sairanen HI (2007) Causes of late deaths after pediatric cardiac surgery: A population-based study. J Am Coll Cardiol 50(13):1263–1271CrossRefPubMed
29.
Hernandez-Madrid A, Paul T, Abrams D et al (2018) Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 20(11):1719–1753CrossRefPubMed
30.
Vehmeijer JT, Mulder BJ, de Groot JR (2018) Current state of risk stratification for sudden cardiac death in adults with congenital heart disease. Anatol J Cardiol 19(6):401–403PubMedPubMedCentral
31.
Pujol C, Niesert AC, Engelhardt A et al (2016) Usefulness of direct oral anticoagulants in adult congenital heart disease. Am J Cardiol 117(3):450–455CrossRefPubMed
32.
Kaemmerer H, Apitz C, Brockmeier K et al (2018) Pulmonary hypertension in adults with congenital heart disease: Updated recommendations from the Cologne Consensus Conference. Int J Cardiol 272:79–88CrossRef
33.
Hjortshøj CS, Jensen AS, Sørensen K et al (2017) Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977–2012. Heart 103(17):1353–1358CrossRefPubMed
34.
Kaemmerer H, Apitz C, Brockmeier K et al (2016) Pulmonary hypertension in grown-ups with congenital heart disease: Recommendations of the Cologne Consensus Conference 2016. Dtsch Med Wochenschr 141(1):70–79
35.
Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119CrossRefPubMed
36.
Brida M, Gatzoulis MA (2018) Pulmonary arterial hypertension in adult congenital heart disease. Heart 104(19):1568–1574CrossRefPubMed
37.
Baddour LM, Wilson WR, Bayer AS et al (2015) Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486CrossRefPubMed
38.
Cresti A, Chiavarelli M, Scalese M et al (2017) Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther 7(1):27–35CrossRefPubMedPubMedCentral
39.
Montanaro C, Dimopoulos K, Shore DF (2017) Infective endocarditis in patients with congenital heart disease: When, where and how. Int J Cardiol 249:171–172CrossRefPubMed
40.
Moore B, Cao J, Kotchetkova I, Celermajer DS (2017) Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. Int J Cardiol 249:161–165CrossRefPubMed
41.
Kuijpers JM, Koolbergen DR, Groenink M et al (2017) Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: Focus on the use of prosthetic material. Eur Heart J 38(26):2048–2056PubMed
42.
Lluri G, Levi DS, Miller E, Hageman A, Sinha S, Sadeghi S et al (2018) Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement. Catheter Cardiovasc Interv 91(2):277–284CrossRefPubMed
43.
Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128CrossRefPubMed
44.
Pizzi MN, Dos-Subirà L, Roque A et al (2017) 18F-FDG-PET/CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material. Int J Cardiol 248:396–402CrossRefPubMed
45.
Naber C, Al-Nawas B, Baumgartner H et al (2007) Prophylaxe der infektiösen Endokarditis. Kardiologe 1:243–250CrossRef
46.
Khan O, Shafi AM, Timmis A (2016) International guideline changes and the incidence of infective endocarditis: A systematic review. Open Heart 3(2):e498CrossRefPubMedPubMedCentral
47.
Cahill TJ, Baddour LM, Habib G et al (2017) Challenges in infective endocarditis. J Am Coll Cardiol 69(3):325–344CrossRefPubMed
48.
Albes J (2018) Endokarditisprophylaxe. Z Herz- Thorax- Gefäßchir 32:492–501CrossRef
49.
Bauer UM, Helm PC, Diller GP et al (2017) Are adults with congenital heart disease informed about their risk for infective endocarditis and treated in accordance to current guidelines? Int J Cardiol 245:105–108CrossRefPubMed
50.
51.
von Kodolitsch Y, Rybczynski M, Vogler M et al (2016) The role of the multidisciplinary health care team in the management of patients with Marfan syndrome. J Multidiscip Healthc 3(9):587–614CrossRef
52.
Hiratzka LF, Bakris GL, Beckman JA et al (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121(13):e266–e369PubMed
53.
Von Kodolitsch Y, De Backer J, Schüler H et al (2015) Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Appl Clin Genet 8:137–155CrossRef
54.
Moons P, Van Deyk K, Marquet K et al (2005) Individual quality of life in adults with congenital heart disease: A paradigm shift. Eur Heart J 26(3):298–307CrossRefPubMed
55.
Apers S, Kovacs AH, Luyckx K et al (2016) Quality of life of adults with congenital heart disease in 15 countries: Evaluating country-specific characteristics. J Am Coll Cardiol 67(19):2237–2245CrossRefPubMed
56.
Eslami B, Sundin O, Macassa G et al (2013) Anxiety, depressive and somatic symptoms in adults with congenital heart disease. J Psychosom Res 74(1):49–56CrossRefPubMed
57.
Jackson JL, Leslie CE, Hondorp SN (2018) Depressive and anxiety symptoms in adult congenital heart disease: Prevalence, health impact and treatment. Prog Cardiovasc Dis 61(3–4):294–299CrossRefPubMed
58.
van Rijen EH, Utens EM, Roos-Hesselink JW, Meijboom FJ, van Domburg RT, Roelandt JR et al (2005) Longitudinal development of psychopathology in an adult congenital heart disease cohort. Int J Cardiol 99(2):315–323CrossRefPubMed
59.
Lesch W, Specht K, Lux A et al (2014) Disease-specific knowledge and information preferences of young patients with congenital heart disease. Cardiol Young 24(2):321–330CrossRefPubMed
60.
Kaemmerer H, Mebus S, Schulze-Neick I et al (2010) The adult patient with Eisenmenger syndrome: A medical update after dana point part I: Epidemiology, clinical aspects and diagnostic options. Curr Cardiol Rev 6(4):343–355CrossRefPubMedPubMedCentral
Metadaten
Titel
Medizinische Versorgung von Erwachsenen mit angeborenen Herzfehlern
Gegenwart und Zukunft
verfasst von
Dr. phil. R. Neidenbach, M.Sc.
S. Achenbach
C. Andonian
J. Beckmann
S. Biber
S. Dittrich
P. Ewert
S. Freilinger
M. Huntgeburth
N. Nagdyman
R. Oberhoffer
L. Pieper
Y. von Kodolitsch
M. Weyand
U. M. M. Bauer
Prof. Dr. Dr. H. Kaemmerer
Publikationsdatum
01.07.2019
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 6/2019
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-019-4820-9

Weitere Artikel der Ausgabe 6/2019

Herz 6/2019 Zur Ausgabe

Main topic

COPD and heart failure: differential diagnosis and comorbidity

Main topic

Right ventricular function in pulmonary (arterial) hypertension

Review articles

Cardiovascular outcome in type 2 diabetes and atrial fibrillation

Original articles

Transient elevation of high-sensitive troponin T after Cardioband implantation

Main topic

Pulmonary and cardiac drugs: clinically relevant interactions

Originalarbeiten

Schwerwiegende unerwünschte Ereignisse in klinischen Prüfungen mit TAVR und SAVR